Showing results (51-60 of 324) with videos related to
Sort By:
Pageof 33
Urologic Oncology|June 17, 2008
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinomaChia-Chi Lin, Yeong-Shiau Pu, Chih-Hung Hsu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancerJenn-Yu Wu, Chong-Jen Yu, Yeun-Chung Chang, et al.Lung Cancer (Amsterdam, Netherlands)|September 14, 2007
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapyChao-Chi Ho, Sung-Hsin Kuo, Pei-Hsin Huang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factorsKuan-Yu Chen, Jen-Hau Chen, Jin-Yuan Shih, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 26, 2010
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancerJih-Hsiang Lee, Chong-Jen Yu, Kuan-Yu Chen, et al.Medicine|April 23, 2011
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutationsJenn-Yu Wu, Jin-Yuan Shih, Kuan-Yu Chen, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 1, 2018
Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese studyTing-Hui Wu, Lukas Jyuhn-Hsiarn Lee, Chang-Tsu Yuan, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 25, 2013
Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: an open-label single-arm studyGee-Chen Chang, Chun-Ming Tsai, Te-Chun Hsia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2019
Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung CancerChia-Chi Hsu, Bin-Chi Liao, Wei-Yu Liao, et al.Lung Cancer (Amsterdam, Netherlands)|March 17, 2015
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusionTzu-Hsiu Tsai, Shang-Gin Wu, Min-Shu Hsieh, et al.Pageof 33